Pusan National University Researchers Identify Potential New Second-Line Option for Advanced Biliary Tract Cancer
Researchers find that FOLFIRINOX, a chemotherapy used for pancreatic cancer, may improve survival in advanced biliary tract cancer patients A new collaborative study from Pusan National University and Yonsei University suggeststhat the FOLFIRINOX regimen showed numerically improved survival outcomes compared to current standards such as FOLFOX, FOLFIRI, and nal-IRI/FL, while maintaining manageable toxicity levels. These […]